Astaxanthin is a red-orange keto-carotenoid produced primarily by the microalgae Haematococcus pluvialis. Unlike most antioxidants, it spans both the lipid and aqueous phases of cell membranes, allowing it to quench free radicals and singlet oxygen across different biological compartments. Clinical trials have examined its effects on skin aging, eye circulation, joint comfort, and cardiovascular markers, making it one of the more studied marine carotenoids in the supplement space.
Trials of natural astaxanthin from Haematococcus pluvialis using doses up to 12 mg per day for 12 weeks have not reported serious adverse events. In the United States it has FDA GRAS notices as a food ingredient at small amounts per serving, which is not an approval of supplement doses [18][19]. That said, the complete picture of its side effects, including who should exercise caution and why, is worth understanding before you decide to supplement.
Key Takeaways
- Astaxanthin at doses up to 12 mg per day for 12 weeks has shown no serious adverse events in clinical trials [1][2].
- Skin discoloration (carotenodermia) is well documented for very high beta-carotene intake but has not been reported in published human astaxanthin studies.
- No gastrointestinal side effect from astaxanthin alone is documented in the trials cited here; the only event attributed to the test material in one open-label study was red stool. Astaxanthin is fat-soluble, and taking it with a fat-containing meal improves absorption[14] [13].
- Astaxanthin is not recommended during pregnancy or breastfeeding due to insufficient safety data in those populations.
- People taking blood pressure medications, statins, or immunosuppressants should consult a doctor before adding astaxanthin to their routine, because trial results on cardiovascular markers are mixed and no interaction trial has been done [20][21][22].
Overall Safety Profile in Clinical Trials
Across published randomized controlled trials, astaxanthin has demonstrated a consistently favorable tolerability profile at typical supplemental doses. A systematic review of clinical studies examining astaxanthin’s effects on skin health found no serious adverse events reported across the included trials [1]. Participants generally completed these studies without significant safety complaints, which is a meaningful baseline signal.
A multicenter randomized double-blinded placebo-controlled trial evaluating a combination of krill oil, astaxanthin, and oral hyaluronic acid in adults with mild osteoarthritis also concluded that the intervention was safe and well-tolerated, with no serious adverse events attributed to the supplement over the study period [2]. A separate randomized trial in individuals with prediabetes and dyslipidaemia that examined astaxanthin’s effects on cholesterol and cardiovascular risk markers likewise found no clinically significant safety concerns among participants [4].
It is honest to note that many trials involve relatively small sample sizes and short durations, typically 8 to 12 weeks. Long-term safety data beyond a few months is limited, and that gap is something careful consumers should weigh.
Dose Range and Duration in Human Trials
The safety signal is only as wide as the doses and durations that were tested, so the details matter. In a randomized, placebo-controlled trial of 35 healthy adults, 6 mg of astaxanthin per day from a Haematococcus pluvialis extract for 8 weeks produced no clinically important differences from placebo in blood pressure or blood chemistry; serum calcium, total protein and eosinophils differed statistically, but the authors judged the differences too small to matter[12]. In a separate evaluation, extracts equivalent to 4, 8 or 20 mg per day were given to 73, 38 and 16 healthy adults for 4 weeks, and no abnormality was observed in the blood parameters measured[13].
No safety concerns were reported in healthy adults at 6 to about 45 mg a day, but the evidence is short or supplier-linked
Short-term tolerability in healthy adults looks good, but long-term and pregnancy safety are not settled.
Healthy adults only. Bars show the dose studied, not a recommended dose. Source: Spiller et al., Journal of Medicinal Food 2003; Satoh et al., Journal of Clinical Biochemistry and Nutrition 2009; Nishida et al., Marine drugs 2023; EFSA 2020.
Data table
| Item | Value |
|---|---|
| 6 mg a day | 6mg per day |
| 12 mg a day, over 6 months | 12mg per day |
| Up to 20 mg a day, 4 weeks | 20mg per day |
| 24 mg a day, 12 weeks | 24mg per day |
| About 45 mg a day, 4 weeks | 45mg per day |
Embed this chart
Free to reuse on your site. Copy the code below; please keep the credit link.
Research note: A review reports no clinical safety concerns in short-term studies at doses up to 24 mg astaxanthin per day for 12 weeks, nor in long-term studies of more than 6 months at 12 mg per day in healthy people. Several of its authors are employed by astaxanthin suppliers [24].
Two small trials went higher. One gave 16 mg or 40 mg per day for 4 weeks to patients with functional dyspepsia, 44 per group including placebo[15]; the other gave heavy smokers 5, 20 or 40 mg per day for 3 weeks, 13 per group[16]. Neither was designed as a safety study and their abstracts report no adverse-event data, so they show that these doses have been given, not that they are proven harmless.
The longest randomized trial ran for a year. In the XANTHIN trial, 61 renal transplant recipients took 12 mg of astaxanthin per day or placebo, and 58 completed it. It found no significant between-group differences in arterial stiffness, oxidative stress, inflammation or any secondary outcome, and the authors noted that larger-than-expected variability reduced its power[9]. It was an efficacy trial and its abstract reports no adverse-event findings, so it is best read as evidence that most participants stayed on 12 mg daily for twelve months rather than as a formal safety result.
Two recent randomized trials at 12 mg per day were short. In a crossover trial of 15 career firefighters over 4 weeks, self-reported side effects were not significantly affected by astaxanthin[10]. In 80 patients with community-acquired pneumonia given 12 mg per day for 7 days alongside antibiotics, the authors judged it safe and well tolerated, and IL-6 and TNF-alpha were significantly lower than with placebo[11].
Formulation changes exposure. In a single-dose study of 40 mg in healthy men, three lipid-based formulations gave 1.7 to 3.7 times the bioavailability of a commercial food supplement[14], so the same labeled dose can mean different blood levels from different products.
Regulatory Status, Natural vs. Synthetic, and Animal Toxicology
GRAS status reflects expert consensus that a substance is safe under its intended conditions of use. It is not drug approval and not a statement that any dose is safe. Approved or recommended astaxanthin doses differ by country, ranging from 2 to 24 mg per day according to a safety review that also examined 87 human studies of natural astaxanthin; none found safety concerns, and 35 used 12 mg per day or more[7].
That review makes a point worth keeping in mind when reading any safety headline: synthetic astaxanthin is chemically different from the natural form, so toxicology done on the synthetic material should not be used to judge natural astaxanthin. It also noted that an earlier European acceptable daily intake of 2 mg had been derived from a rat study using synthetic astaxanthin[7]. The European Food Safety Authority panel for feed additives later set an acceptable daily intake of 0.2 mg per kg of body weight per day. It reached that figure by applying an uncertainty factor of 200 to a lowest observed adverse effect level of 40 mg per kg per day, based on more multinucleated liver cells in a 2-year carcinogenicity study, and it replaced a 2014 value of 0.034 mg per kg[17]. A 200-fold safety factor makes this a conservative regulatory ceiling rather than the point at which harm begins, and it came from an opinion on a feed additive for fish.
EFSA’s novel food panel later concluded that the same acceptable daily intake applies to astaxanthin from Haematococcus pluvialis, and that 8 mg per day from food supplements is safe for adults even on top of a high estimate of astaxanthin from the background diet. That same scenario exceeds the acceptable daily intake in children below 14 years of age, from 28% in children aged 10 to under 14 up to 524% in infants aged 4 to 6 months. The EU authorises supplements up to a maximum of 8 mg astaxanthin per day [25].
The animal data that sit behind these numbers come from a review of genotoxicity and rat carcinogenicity studies of synthetic astaxanthin. The Ames and in vitro micronucleus tests showed no genotoxic potential, and a long-term mouse study showed no carcinogenicity. In the rat study, fed 40, 200 or 1000 mg per kg of body weight per day, benign liver adenomas appeared in females only, at 200 mg per kg per day and above, together with changes indicating slight liver toxicity and regeneration. The reviewers concluded the adenomas were secondary to that liver injury and most probably specific to the species, of doubtful human relevance[8]. The review’s authors work for a manufacturer of synthetic astaxanthin, and these doses are far above anything given to people. None of the human trial abstracts cited on this page reports liver problems, but none was designed to look for them, so anyone with liver disease should ask a clinician before supplementing.
Skin Color and Carotenodermia
Carotenodermia is a reversible yellowing or orange tinting of the skin. It is well documented for very high beta-carotene intake, but it has not been reported in published human astaxanthin studies, and the 20 mg per day threshold quoted online does not trace to a study.
Where carotenodermia does occur, it is harmless and reversible when intake is reduced or stopped. Critically, it is not the same as jaundice: in carotenodermia the whites of the eyes remain clear, whereas jaundice involves yellowing of the sclera and indicates liver involvement. If you notice unexpected skin color change while supplementing, reducing your dose is a reasonable first step and mentioning it to a doctor is wise.
Gastrointestinal Effects
In an open-label study in which 127 healthy adults took 4, 8 or 20 mg per day for 4 weeks, no adverse effects or laboratory abnormalities were observed, and the only event attributed to the test material was red-coloured stool, which the authors linked to the colour of the material itself. Stomach upset and looser stools are often listed as possible effects, but the astaxanthin trials cited here do not document them [13].
The one tolerability trial cited here that reported gastrointestinal symptoms tested 4 g per day of krill powder, a source of EPA and DHA, rather than astaxanthin alone. In its 35 overweight adults over 8 weeks, flatulence, heartburn and diarrhea were the events most often judged probably related to the products, there were fewer adverse events in the krill group than in the placebo group (30 versus 50), and none were serious[3]. It cannot tell us whether astaxanthin itself upsets the stomach. Because astaxanthin is fat-soluble, absorption is enhanced when it is taken with a meal containing dietary fat[14].
Cardiovascular Markers and Medication Interactions
Trial results on cardiovascular risk markers are mixed. A randomized trial in 36 people with prediabetes and dyslipidemia found that 12 mg per day for 24 weeks lowered total and LDL cholesterol[4], whereas a meta-analysis of 7 randomized trials found no significant effect on total cholesterol, LDL, HDL or triglycerides [21][20][23]. A study examining a nutraceutical combination in individuals with mild to moderate dyslipidemia also explored cholesterol-related outcomes, though this involved a multi-ingredient formula rather than astaxanthin alone [5].
These cardiovascular effects are generally framed as potential benefits, but they carry a practical implication for people already on prescription medications. If you take blood pressure medications, statins, fibrates, or other lipid-lowering drugs, there is a theoretical possibility of additive effects on blood pressure or lipid levels. Robust clinical evidence for a harmful drug interaction is currently lacking, but the appropriate stance is caution rather than assumption of safety. Discussing astaxanthin with your prescribing physician before combining it with these medications is a sensible step.
Anticoagulants such as warfarin are a further theoretical concern, and so are drugs that act on the immune system, because astaxanthin lowered inflammatory markers in the pneumonia trial[11]. No trial cited here tested an interaction with either class, so this is a reason to ask, not evidence of harm.
Pregnancy, Breastfeeding, and Vulnerable Populations
The evidence base for astaxanthin supplementation during pregnancy or breastfeeding is insufficient to establish safety. No adequately powered human trials have assessed outcomes in pregnant women or nursing mothers. Until that data exists, supplementation during pregnancy or breastfeeding is not recommended. This is a precautionary stance based on an evidence gap, not a confirmed signal of harm.
Children represent another group where caution is warranted simply due to the absence of pediatric safety data. People with autoimmune conditions or those taking immunosuppressant therapy should also consult a healthcare provider before supplementing. Astaxanthin has theoretical immune-modulating properties based on its antioxidant and anti-inflammatory mechanisms, and interactions with immunosuppressant drugs have not been studied in human trials.
Individuals with hormone-sensitive conditions should also raise astaxanthin with their specialist before starting, given some preclinical interest in how carotenoids may influence related biochemical pathways. No clinical trial we are aware of directly addresses this, so the guidance is precautionary.
Product Source, Quality and Allergies
Most of the safety data above concerns natural astaxanthin from Haematococcus pluvialis, so the label matters: look for the source organism and the astaxanthin content per serving, and be aware that synthetic astaxanthin, which is mainly made for fish feed, is a different compound[7]. Supplement quality is not pre-checked before sale, so products that publish third-party testing are the more reassuring choice. People with shellfish allergies should confirm the source on the label, since astaxanthin is also associated with crustaceans in food.
Eye Circulation and the Limits of Current Evidence
One area where astaxanthin’s effects show up in clinical data involves ocular circulation. A clinical study found that astaxanthin increased choroidal blood flow velocity, a measure of circulation in the tissue layer behind the retina [6]. This is generally considered a potential benefit given the relevance of choroidal circulation to retinal health, and no adverse ocular effects were reported in that study.
More broadly, it is worth being realistic about the current evidence. Most human trials are short, conducted in adults with specific health conditions, and use astaxanthin sometimes in combination with other compounds such as krill oil or hyaluronic acid [2]. Isolating the effects of astaxanthin alone, including its side effects, from combination-formula studies requires some interpretive care. The absence of serious reported adverse events across this body of evidence is encouraging, but it does not mean risk is zero across all populations and durations.
🛒 Where to Buy Astaxanthin
- Nutrex Hawaii BioAstin Hawaiian Astaxanthin
softgels, 12 mg per softgel, 90 count: Hawaiian-grown Haematococcus pluvialis, sold as the High Potency 90-softgel bottle - Pure Synergy SuperPure Astaxanthin Extract
capsules, 60 count: Sold as an astaxanthin extract in a capsule rather than a softgel; the listing does not state a mg per capsule, so check the label for the dose before comparing it with the 12 mg bottles here - Naturalis New Zealand Astaxanthin
softgels, 12 mg per softgel, 120 count: New Zealand-grown rather than Hawaiian, and the largest bottle on this list at 120 softgels - NOW Foods Astaxanthin
softgels, 4 mg per softgel: The entry-level 4 mg dose, built on the Zanthin astaxanthin ingredient; a lower starting point than the 12 mg bottles above
As an Amazon Associate we earn from qualifying purchases. Astaxanthin products vary mainly by dose and by source, with 4mg and 12mg the common strengths and most of them derived from Haematococcus pluvialis algae, so check the label for the astaxanthin content per serving and prefer products that publish third-party testing.
A Note on the Evidence
The clinical trial database for astaxanthin in humans remains relatively small, with most studies lasting 8 to 12 weeks and enrolling healthy or mildly affected adults; long-term and large-population safety data are still limited. People who are pregnant, breastfeeding, taking prescription medications, or managing chronic health conditions should consult a qualified healthcare provider before starting astaxanthin supplementation, and nothing in this article constitutes medical advice.
Frequently Asked Questions
Is astaxanthin safe to take every day?
Clinical trials have found astaxanthin to be well-tolerated at doses up to 12 mg per day over periods of 8 to 12 weeks, with no serious adverse events reported [1][2]. Long-term daily use beyond several months has not been as thoroughly studied in humans, so periodic reassessment with a healthcare provider is a reasonable practice.
Can astaxanthin really turn your skin orange?
Not in the published human studies. Skin discoloration (carotenodermia) is well documented for very high beta-carotene intake but has not been reported in published human astaxanthin studies, and it was not reported as a significant problem at the doses used in most clinical trials (4 to 12 mg per day) [1]. Where carotenodermia does occur, it is a reversible orange-yellow tint and not a sign of liver disease.
Does astaxanthin interact with cholesterol or blood pressure medications?
Trial results on cholesterol are mixed: one 24-week trial in 36 people with prediabetes and dyslipidemia taking 12 mg per day found lower total and LDL cholesterol[4], while a meta-analysis of 7 randomized trials found no significant effect on total cholesterol, LDL, HDL or triglycerides. Any lowering raises [21][20][23] the theoretical possibility of additive effects when combined with lipid-lowering or blood pressure drugs. No serious interactions have been confirmed in clinical trials, but anyone on these medications should discuss supplementation with their prescribing doctor before starting.
Are there any known effects of astaxanthin on the eyes?
A clinical study found that astaxanthin increased choroidal blood flow velocity, a measure of circulation behind the retina [6]. This is generally considered a potential benefit. No adverse effects on eye health have been reported in the published clinical trial literature covered here.
Is it safe to take astaxanthin during pregnancy?
There is insufficient clinical evidence to establish the safety of astaxanthin supplementation during pregnancy or breastfeeding. The precautionary recommendation is to avoid supplementation during these periods until adequate human data exists. This is not a confirmed signal of harm but an honest acknowledgment of what is not yet known.
What is the safest dose of astaxanthin?
Human clinical trials have most commonly used doses in the range of 4 to 12 mg per day, and this range has not produced serious adverse events in the studies reviewed [1][2][4]. There is no established universal safe upper limit for all populations, and individual factors including age, health status, and medications matter.
Is astaxanthin FDA approved or just a supplement?
Astaxanthin supplements are not FDA approved. FDA GRAS notices for Haematococcus pluvialis extract have covered its use as a food ingredient, at 0.1 mg of astaxanthin per serving in one notice and a maximum of 0.15 mg per serving in another, and FDA responded that it had no questions. EFSA has not approved any health claims for astaxanthin in Europe [18][19][24]. GRAS reflects expert consensus on safety under intended conditions of use; it is not the same as drug approval, which requires demonstrated therapeutic efficacy in regulated trials.
Has astaxanthin been shown to cause cancer in animal studies?
A review of toxicology studies of synthetic astaxanthin found no genotoxic potential in the Ames and micronucleus tests and no carcinogenicity in a long-term mouse study. In a rat study, benign liver adenomas appeared in females only, at 200 mg per kg per day and above, together with slight liver toxicity; the reviewers judged them secondary to that injury, probably specific to the species and of doubtful human relevance. The review’s authors work for a manufacturer of synthetic astaxanthin.[8]
Can astaxanthin cause liver damage?
In rats given doses of 200 mg per kg per day and above, slight liver toxicity and regeneration were seen in females. The human trials cited on this page do not report liver problems, but they were not designed to detect them. People with existing liver conditions should talk to a clinician before supplementing.[8]
Is natural astaxanthin safer than synthetic astaxanthin?
Natural astaxanthin from Haematococcus pluvialis is the form used in most human clinical research. Synthetic astaxanthin is chemically different and is mainly produced for fish feed, and a safety review concluded that results from synthetic material should not be used to judge the safety of the natural form. Check the label for the source and for third-party testing.[7]
Is there an official upper limit for astaxanthin?
There is no single agreed limit. The European Food Safety Authority panel for feed additives set an acceptable daily intake of 0.2 mg per kg of body weight per day by applying an uncertainty factor of 200 to an animal effect level, and the EU authorises supplements up to 8 mg per day [25]. It is a conservative regulatory ceiling, not the dose at which harm begins, and approved or recommended doses range from 2 to 24 mg per day across countries.[17]
References
- Ng QX et al. Effects of Astaxanthin Supplementation on Skin Health: A Systematic Review of Clinical Studies. Journal of dietary supplements (2021). PMID 32202443
- Hill WS et al. A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of a Krill Oil, Astaxanthin, and Oral Hyaluronic Acid Complex on Joint Health in People with Mild Osteoarthritis. Nutrients (2023). PMID 37686801
- Sarkkinen ES et al. Prospective, randomized, double-blinded, placebo-controlled study on safety and tolerability of the krill powder product in overweight subjects with moderately elevated blood pressure. Lipids in health and disease (2018). PMID 30572894
- Ciaraldi TP et al. Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia. Diabetes, obesity & metabolism (2023). PMID 36999233
- Barrios V et al. A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence. Atherosclerosis. Supplements (2017). PMID 27998714
- Saito M et al. Astaxanthin increases choroidal blood flow velocity. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2012). PMID 22072378
- Brendler T, Williamson EM. Astaxanthin: How much is too much? A safety review. Phytotherapy Research (2019). PMID 31788888
- Edwards JA et al. Review of genotoxicity and rat carcinogenicity investigations with astaxanthin. Regulatory Toxicology and Pharmacology (2016). PMID 26713891
- Coombes JS, Sharman JE, Fassett RG. Astaxanthin has no effect on arterial stiffness, oxidative stress, or inflammation in renal transplant recipients: a randomized controlled trial (the XANTHIN trial). American Journal of Clinical Nutrition (2016). PMID 26675778
- Gonzalez DE et al. Impact of astaxanthin supplementation on markers of cardiometabolic health and tactical performance among firefighters. Journal of the International Society of Sports Nutrition (2024). PMID 39568140
- Youssef FM et al. The anti-inflammatory and antioxidant effects of astaxanthin as an adjunctive therapy in community-acquired pneumonia: a randomized controlled trial. Frontiers in Pharmacology (2025). PMID 40852606
- Spiller GA, Dewell A. Safety of an astaxanthin-rich Haematococcus pluvialis algal extract: a randomized clinical trial. Journal of Medicinal Food (2003). PMID 12804020
- Satoh A et al. Preliminary Clinical Evaluation of Toxicity and Efficacy of A New Astaxanthin-rich Haematococcus pluvialis Extract. Journal of Clinical Biochemistry and Nutrition (2009). PMID 19430618
- Mercke Odeberg J, Lignell A, Pettersson A, Höglund P. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. European Journal of Pharmaceutical Sciences (2003). PMID 12885395
- Kupcinskas L et al. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: a prospective, randomized, double blind, and placebo-controlled study. Phytomedicine (2008). PMID 18467083
- Kim JH et al. Protective effects of Haematococcus astaxanthin on oxidative stress in healthy smokers. Journal of Medicinal Food (2011). PMID 21883001
- EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). Safety and efficacy of astaxanthin-dimethyldisuccinate (Carophyll Stay-Pink 10%-CWS) for salmonids, crustaceans and other fish. EFSA Journal (2019). PMID 32626207
- US Food and Drug Administration GRN No. 294: Haematococcus pluvialis extract containing astaxanthin esters. US Food and Drug Administration (2010). source
- US Food and Drug Administration GRN No. 580: Haematococcus pluvialis extract containing astaxanthin esters. US Food and Drug Administration (2015). source
- Sorin Ursoniu et al. Systematic review/Meta-analysis Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials. Archives of Medical Science (2015). PMID 25995739
- Gao C et al. The Effects of Astaxanthin on Metabolic Syndrome: A Comprehensive Review. Marine drugs (2024). PMID 39852511
- Leung LY et al. Astaxanthin Influence on Health Outcomes of Adults at Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis. Nutrients (2022). PMID 35631193
- Kishimoto Y et al. Potential Anti-Atherosclerotic Properties of Astaxanthin. Marine drugs (2016). PMID 26861359
- Nishida Y et al. Astaxanthin: Past, Present, and Future. Marine drugs (2023). PMID 37888449
- European Food Safety Authority (EFSA NDA Panel) Safety of astaxanthin for its use as a novel food in food supplements. European Food Safety Authority (EFSA NDA Panel) (2020). source
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
